Literature DB >> 20693381

Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients.

Mariano Esperatti1, Miquel Ferrer, Anna Theessen, Adamantia Liapikou, Mauricio Valencia, Lina Maria Saucedo, Elisabeth Zavala, Tobias Welte, Antoni Torres.   

Abstract

RATIONALE: Most current information on hospital-acquired pneumonia (HAP) is extrapolated from patients with ventilator-associated pneumonia (VAP). No studies have evaluated HAP in the intensive care unit (ICU) in nonventilated patients.
OBJECTIVES: To compare pneumonia acquired in the ICU by mechanically ventilated versus nonventilated patients.
METHODS: We prospectively collected 315 episodes of ICU-acquired pneumonia. We compared clinical and microbiologic characteristics of patients with VAP (n = 164; 52%) and nonventilator ICU-acquired pneumonia (NV-ICUAP; n = 151; 48%). Among NV-ICUAP patients, 79 (52%) needed subsequent intubation.
MEASUREMENTS AND MAIN RESULTS: Compared with NV-ICUAP, patients with VAP were more severe (APACHE-II 17 ± 6 vs. 15 ± 5; P < 0.001) and pneumonia occurred later in the ICU (8 ± 8 vs. 5 ± 6 d; P < 0.001). Etiologic diagnosis (117, 71% vs. 64, 42%; P < 0.001), nonfermenting (28% vs. 15%; P = 0.009) and enteric gram-negative bacilli (26% vs. 13%; P = 0.006), and methicillin-sensitive Staphylococcus aureus (14% vs. 6%; P = 0.031) were more frequent in VAP, likely caused by more patients with lower respiratory tract samples cultured (100% vs. 84%; P < 0.001). However, in patients with defined etiology only, the proportion of pathogens was similar between groups, except for a higher proportion of Streptococcus pneumoniae in NV-ICUAP (P = 0.045). The hospital mortality also was similar.
CONCLUSIONS: Despite a lower proportion of pathogens in NV-ICUAP compared with VAP, the type of isolates and outcomes are similar regardless of whether pneumonia is acquired or not during ventilation, indicating they may depend on patients' underlying severity rather than previous intubation. With the diagnostic techniques currently recommended by guidelines, both types of patients might receive similar empiric antibiotic treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20693381     DOI: 10.1164/rccm.201001-0094OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  51 in total

Review 1.  [Severe pneumonia in the intensive care unit].

Authors:  T Welte
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-09       Impact factor: 0.840

2.  Comment on "Pneumonia associated with invasive and noninvasive ventilation: an analysis of the German nosocomial infection surveillance system database".

Authors:  Miquel Ferrer; Antoni Torres
Journal:  Intensive Care Med       Date:  2011-03-05       Impact factor: 17.440

Review 3.  Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?

Authors:  Andrea Endimiani; Kristine M Hujer; Andrea M Hujer; Sebastian Kurz; Michael R Jacobs; David S Perlin; Robert A Bonomo
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 4.  Update in pulmonary infections 2010.

Authors:  Richard G Wunderink; Grant W Waterer
Journal:  Am J Respir Crit Care Med       Date:  2011-07-15       Impact factor: 21.405

5.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

6.  Noninvasive ventilation after early extubation in patients recovering from hypoxemic acute respiratory failure: a single-centre feasibility study.

Authors:  Rosanna Vaschetto; Emilia Turucz; Fabrizio Dellapiazza; Stefania Guido; Davide Colombo; Gianmaria Cammarota; Francesco Della Corte; Massimo Antonelli; Paolo Navalesi
Journal:  Intensive Care Med       Date:  2012-07-24       Impact factor: 17.440

7.  Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study.

Authors:  Marta Di Pasquale; Mariano Esperatti; Ernesto Crisafulli; Miquel Ferrer; Gianluigi Li Bassi; Mariano Rinaudo; Angels Escorsell; Javier Fernandez; Antoni Mas; Francesco Blasi; Antoni Torres
Journal:  Intensive Care Med       Date:  2013-08-02       Impact factor: 17.440

8.  Nosocomial pneumonia in the intensive care unit: how should treatment failure be predicted?

Authors:  Otavio T Ranzani; Elena Prina; Antoni Torres
Journal:  Rev Bras Ter Intensiva       Date:  2014 Jul-Sep

9.  Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?

Authors:  J Ruiz-Ramos; P Vidal-Cortés; A Díaz-Lamas; R Reig-Valero; F Roche-Campo; M Del Valle-Ortiz; X Nuvials-Casals; M Ortiz-Piquer; D Andaluz-Ojeda; L Tamayo-Lomas; M A Blasco-Navalpotro; M Rodriguez-Aguirregabiria; J Aguado; P Ramirez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-04       Impact factor: 3.267

10.  Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.

Authors:  George H Talbot; Anita Das; Stephanie Cush; Aaron Dane; Michele Wible; Roger Echols; Antoni Torres; Sue Cammarata; John H Rex; John H Powers; Thomas Fleming; Jeffrey Loutit; Steve Hoffmann
Journal:  J Infect Dis       Date:  2019-04-19       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.